Solveig Nora Daecke

The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo

Annkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke et al. · Blood · 2013 · 345 citations · Full text

Life Sciences, Immunology, Pharmacology +10

Generation and functional characterization of MDSC-like cells

Annkristin Heine, Stefanie Andrea Erika Held, Jonas Schulte-Schrepping et al. · OncoImmunology · 2017 · 48 citations · Full text

Life Sciences, Immunology, Pathology +16

Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma

Ruth-Miriam Koerber, Stefanie Andrea Erika Held, Annkristin Heine et al. · Experimental Hematology and Oncology · 2015 · 31 citations · Full text

Medicine, Oncology, Pharmacology +16

Regulation of dectin-1–mediated dendritic cell activation by peroxisome proliferator–activated receptor-gamma ligand troglitazone

Grethe Kock, Anita Bringmann, Stefanie Andrea Erika Held et al. · Blood · 2011 · 31 citations

Life Sciences, Immunology, Pharmacology +17

The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function

Annkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke et al. · PLoS ONE · 2015 · 31 citations · Full text

Life Sciences, Immunology, Pharmacology +17